iHCK-37 (ASN05260065) is a selective Hck inhibitor with antitumor activity, blocking HIV-1 viral replication. iHCK-37 reduces PI3K/AKT and MAPK/ERK pathway activation after erythropoietin induction in high Hck-expressing cells, useful in chronic myelogenous leukemia (CML) research.
Molecular Weight:
544.73
Purity:
99.97%
CAS Number:
[516478-09-4]
Formula:
C30H32N4O2S2
Target:
Src|||Hck
T40594
T40594
* VAT and and shipping costs not included. Errors and price changes excepted